Literature DB >> 31739217

Chemokine (C-C motif) ligand 2 and coronary artery disease: Tissue expression of functional and atypical receptors.

Anna Hernández-Aguilera1, Montserrat Fibla2, Noemí Cabré3, Fedra Luciano-Mateo4, Jordi Camps5, Salvador Fernández-Arroyo6, Vicente Martín-Paredero7, Javier A Menendez8, Juan J Sirvent9, Jorge Joven10.   

Abstract

Chemokines, particularly chemokine (C-C- motif) ligand 2 (CCL2), control leukocyte migration into the wall of the artery and regulate the traffic of inflammatory cells. CCL2 is bound to functional receptors (CCR2), but also to atypical chemokine receptors (ACKRs), which do not induce cell migration but can modify chemokine gradients. Whether atherosclerosis alters CCL2 function by influencing the expression of these receptors remains unknown. In a necropsy study, we used immunohistochemistry to explore where and to what extent CCL2 and related receptors are present in diseased arteries that caused the death of men with coronary artery disease compared with unaffected arteries. CCL2 was marginally detected in normal arteries but was more frequently found in the intima. The expression of CCL2 and related receptors was significantly increased in diseased arteries with relative differences among the artery layers. The highest relative increases were those of CCL2 and ACKR1. CCL2 expression was associated with a significant predictive value of atherosclerosis. Findings suggest the need for further insight into receptor specificity or activity and the interplay among chemokines. CCL2-associated conventional and atypical receptors are overexpressed in atherosclerotic arteries, and these may suggest new potential therapeutic targets to locally modify the overall anti-inflammatory response.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ACKR; Atherosclerosis; CCL2; CCR2; Inflammation

Mesh:

Substances:

Year:  2019        PMID: 31739217     DOI: 10.1016/j.cyto.2019.154923

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  5 in total

1.  A Network Pharmacology Study to Explore the Underlying Mechanism of Safflower (Carthamus tinctorius L.) in the Treatment of Coronary Heart Disease.

Authors:  Qingwen Meng; Huajiang Liu; Haolin Wu; Ding Shun; Chaoling Tang; Xinyin Fu; Xingyue Fang; Yiqian Xu; Bocen Chen; Yiqiang Xie; Qibing Liu
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-14       Impact factor: 2.650

2.  CCL2, CCR2 Gene Variants and CCL2, CCR2 Serum Levels Association with Age-Related Macular Degeneration.

Authors:  Gaile Gudauskiene; Alvita Vilkeviciute; Greta Gedvilaite; Rasa Liutkeviciene; Dalia Zaliuniene
Journal:  Life (Basel)       Date:  2022-07-12

Review 3.  The Entry and Egress of Monocytes in Atherosclerosis: A Biochemical and Biomechanical Driven Process.

Authors:  Hongyan Kang; Xinyu Li; Kewen Xiong; Zhiyun Song; Jiaxin Tian; Yuqiao Wen; Anqiang Sun; Xiaoyan Deng
Journal:  Cardiovasc Ther       Date:  2021-07-08       Impact factor: 3.023

4.  Systemic overexpression of C-C motif chemokine ligand 2 promotes metabolic dysregulation and premature death in mice with accelerated aging.

Authors:  Fedra Luciano-Mateo; Noemí Cabré; Gerard Baiges-Gaya; Salvador Fernández-Arroyo; Anna Hernández-Aguilera; Elisabet Elisabet Rodríguez-Tomàs; Meritxell Arenas; Jordi Camps; Javier A Menéndez; Jorge Joven
Journal:  Aging (Albany NY)       Date:  2020-10-26       Impact factor: 5.682

5.  Proinflammatory protein signatures in cryptogenic and large artery atherosclerosis stroke.

Authors:  Lukas Holmegaard; Tara M Stanne; Ulf Andreasson; Henrik Zetterberg; Kaj Blennow; Christian Blomstrand; Katarina Jood; Christina Jern
Journal:  Acta Neurol Scand       Date:  2020-12-04       Impact factor: 3.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.